Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 78Lymphoma 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 69Leukemia 69Lymphoma, Non-Hodgkin 68Multiple Myeloma 64Leukemia, Lymphocytic, Chronic, B-Cell 63Lymphoma, Large B-Cell, Diffuse 61Myelodysplastic Syndromes 59Lymphoma, Follicular 59Hodgkin Disease 58Lymphoma, Mantle-Cell 52Lymphoma, Large-Cell, Immunoblastic 48Burkitt Lymphoma 47Lymphoma, B-Cell, Marginal Zone 41Leukemia, Myeloid, Chronic-Phase 40Leukemia, Myeloid, Accelerated Phase 40Congenital Abnormalities 39Neoplasms, Plasma Cell 37Myeloproliferative Disorders 37Leukemia, Myelomonocytic, Chronic 31Waldenstrom Macroglobulinemia 29Recurrence 29Blast Crisis 29Primary Myelofibrosis 23Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23Anemia, Refractory, with Excess of Blasts 21Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 20Dendritic Cell Sarcoma, Interdigitating 20Lymphoma, Large-Cell, Anaplastic 19

Interventions

Cyclophosphamide 5venetoclax 3tagraxofusp 3fludarabine phosphate 3Whole-Body Irradiation 3Thiotepa 3Mycophenolic Acid 3Methotrexate 3merphos 2Tacrolimus 2Cyclosporins 2Cyclosporine 2prednylidene 1lorvotuzumab mertansine 1fludarabine 1exifone 1dexamethasone acetate 1dexamethasone 21-phosphate 1deltacortene 1azathiopurine 1auricularum 1X-Rays 1Vincristine 1Specimen Handling 1Sirolimus 1Rituximab 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Blastic Plasmacytoid Dendritic Cell Neoplasm × Peripheral Blood Stem Cell Transplantation × Clear all
NCT02220985 2026-06-01

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

Fred Hutchinson Cancer Center

Phase 2 Completed
84 enrolled 22 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡